- Home
- /
- Treatment
- /
- Page 50
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
Adeno-associated viral vector serotype 9 containing the human iduronate-2-sulfatase gene | Hunter Syndrome | Laboratorios del Dr Esteve, S.A. | August 10, 2015 |
|
Ibrutinib | Marginal zone lymphoma | Janssen-Cilag International NV | August 10, 2015 |
|
2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt | Hepatocellular Carcinoma | Dr Ulrich Granzer | August 10, 2015 |
|
Lanreotide acetate | Polycystic kidney disease- type 1 | Prof. Dr R.T.Gansevoort | August 10, 2015 |
|
Insulin human | Short bowel syndrome | Sirius Regulatory Consulting Limited | August 10, 2015 |
|
Fibrinogen-coated albumin spheres | Acute Radiation Syndrome Acute radiation syndrome | Fibreu Limited | August 10, 2015 |
|
Adeno-associated viral vector serotype 8 containing the humanMTM1gene | Alport syndrome | Audentes Therapeutics UK Limited | August 10, 2015 |
|
(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes | Khondrion BV | August 10, 2015 |
|
CD33-directed antibody-drug conjugate consisting of an antibody conjugated to a DNA cross-linking pyrrolobenzodiazepine dimer drug | Acute myeloid leukaemia | Seattle Genetics UK, Limited | August 10, 2015 |
|
Human allogeneic bone-marrow-derived osteoblastic cells | Osteogenesis imperfecta | Bone Therapeutics SA | August 10, 2015 |
|
Daratumumab | Follicular lymphoma | Janssen Research & Development, LLC;1400 McKean Road, P. O. Box 776;Spring House, Pennsylvania, 19477 | August 6, 2015 |
|
Sodium valproate | Wolfram syndrome | The University of Birmingham;Birmingham Research Park - Vincent Drive, Birmingham B15 2SQ; | August 5, 2015 |
|
Varlitinib | Bile duct cancer | ASLAN Pharmaceuticals;10A Bukit Pasoh Road, 089824; | August 5, 2015 |
|
Butylidenephthalide | Glioma | Everfront Biotech, Inc.;11F., No. 31, Ln. 169, Kangning St., New Taipei City 221; | August 5, 2015 |
|
Inecalcitol | Acute myeloid leukemia | Hybrigenics, S.A.;3-5 Impasse Reille, 75014;Paris | August 3, 2015 |
|
Afatinib | Non-small cell lung cancer | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, P. O. Box 368;Ridgefield, Connecticut, 06877 | August 3, 2015 |
|
Synthetic hypericin | Cutaneous T-cell lymphoma | Kinesys Consulting Ltd | July 28, 2015 |
|
Modified adenovirus serotype 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand and full length 4-1BBL | Pancreatic Cancer | Lokon Pharma AB | July 28, 2015 |
|
Anti-H5N1 equine immunoglobulin F(ab’)2fragments | Avian influenza | Fab'entech | July 28, 2015 |
|
2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide, tetrahydrochloride | Acute myeloid leukaemia | Pierre Fabre Médicament | July 28, 2015 |
|
Beloranib | Craniopharyngioma | FGK Representative Service GmbH | July 28, 2015 |
|
Adenovirus-associated viral vector serotype 2 containing the humanRPE65gene | Retinitis pigmentosa | Spark Therapeutics Ireland Ltd | July 28, 2015 |
|
Doxorubicin | Hepatoblastoma | Double Bond Pharmaceutical AB | July 28, 2015 |
|
Veltuzumab | Immune thrombocytopenic purpura | Immunomedics, Inc.;300 The American Road;Morris Plains, New Jersey, 07950 | July 28, 2015 |
|
Inecalcitol | Acute myeloid leukaemia | Hybrigenics SA | July 28, 2015 |
